BillionToOne is a molecular counter platform designed to accurately count DNA molecules to the single-count level. With a mission to detect disorders such as cystic fibrosis and sickle-cell disease, the company optimizes the signal-to-noise ratio through blood testing. The platform specializes in both prenatal and oncology divisions. BillionToOne was founded by David Tsao, Oguzhan Atay, and Sukrit Silas in 2016 and is headquartered in San Francisco, CA.

Register for Details

For more details on financing and valuation for BillionToOne, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about BillionToOne

Forge green plus iconForge green minus icon

Is BillionToOne a publicly traded company?

BillionToOne is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

Will BillionToOne go IPO?

BillionToOne has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

Forge green plus iconForge green minus icon

What is BillionToOne's IPO price?

The IPO price for BillionToOne will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in BillionToOne pre-IPO?

BillionToOne is privately held company and is not publicly traded, therefor investing in BillionToOne pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my BillionToOne shares?

To determine the value of your BillionToOne shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your BillionToOne shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell BillionToOne before it goes public?

Yes, you can seek to sell shares in BillionToOne while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is BillionToOne's funding to date?

BillionToOne has raised $407.89MM to date.
Forge green plus iconForge green minus icon

When was BillionToOne founded?

BillionToOne was founded in 2016.

Who are BillionToOne's major investors?

Y Combinator
Adams Street Partners
Premji Invest
Northwest Venture Partners
Hemisphere Ventures
Neuberger Berman
Four Rivers Group
Fifty Years
500 Global
UpHonest Capital
Time BioVentures
Start Capital
Metaplanet Holdings
Neotribe Ventures
HOF Capital
Hummingbird Ventures
U.S. Department of Health and Human Services
Civilization Ventures
NewDo Venture
QB3
Brightway Future Capital
NYX Ventures Partners
Lombardstreet Ventures

BillionToOne funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
6/21/2024

Series D

$130.47MM raised $XXX.XX $XXX.XX
12/15/2022

Series C-1

$33.87MM raised $XXX.XX $XXX.XX
3/30/2022

Series C

$155MM raised $XXX.XX $XXX.XX
7/12/2021

Series B-1

$55MM raised $XXX.XX $XXX.XX
3/10/2020

Series B-2

$16.02MM raised $XXX.XX $XXX.XX
3/28/2019

Series A-6

$15.02MM raised $XXX.XX $XXX.XX
8/22/2017

Series A-1, A-2, A-3, A-4 and A-5

$2.5MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.